海外の治験の状況「1」での検索結果
7748件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- An Observational Study of First-Line Capecitabine Based Chemotherapy in Participants With Metastatic Colorectal Cancer
- Colorectal Cancer;Colorectal Cancer;Colorectal Cancer;Colorectal Cancer
- Hungary
- 2012-09-27
Not recruiting
- Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma
- Lymphoma, T-Cell, Peripheral
- Italy
- 2012-08-30
Not Recruiting
- 2nd line treatment with cabazitaxel in patients with NSCLC
- Patients with stage IIIB with pleural effusion or stage IV NSCLC with documented disease progression during or after completion of docetaxel-based treatment are eligible for the study.;Therapeutic area: Diseases [C] - Cancer [C04]
- Greece
- 2012-08-08
Not recruiting
- Safety and Efficacy Study of MEHD7945A + FOLFIRI Versus Cetuximab + FOLFIRI as Second Line Therapy in Participants With KRAS Wild-Type Metastatic Colorectal Cancer (mCRC)
- Colorectal Cancer
- Australia, Belgium, France, Germany, Italy, New Zealand, Romania, Spain, United Kingdom, United States
- 2012-07-26
Not recruiting
- The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)
- Maturity-onset Diabetes of the Young
- Denmark
- 2012-05-24
Not Recruiting
- An Open-label, Multicenter Phase II Study to Compare the Efficacy and Safety of RAD001 as First-line Followed by Second-line Sunitinib Versus Sunitinib as First-line Followed by Second-line RAD001 in the Treatment of Patients With Metastatic Renal Cell Carcinoma.
- Renal Cell Carcinoma;C65 - Malignant neoplasm of renal pelvis;C64 - Malignant neoplasm of kidney, except renal pelvis
- Argentina, Australia, Brazil, Canada, Denmark, France, Germany, Hong Kong, Italy, Korea, Republic of, Mexico, Netherlands, Peru, Spain, Taiwan, Province of China, Thailand, Turkey, United Kingdom, United States
- 2012-04-30
Not Recruiting
- Phase II study of first-line WHIT panitumumab and capecitabine in elderly patients with metastatic colorectal cancer and wild type KRAS
- First-line treatment for elderly patients with metastatic colorectal cancer (mCRC) and wild type KRAS MedDRA version: 14.1 Level: PT Classification code 10052358 Term: Colorectal cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Spain
- 2012-04-26
Not recruiting
- An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy
- Locally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal Junction;Locally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal Junction;Locally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal Junction;Locally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal Junction
- France, Germany, Hong Kong, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Singapore, Spain, Taiwan, United States
- 2012-04-25
Not Recruiting
- Phase I, Open-label, Non-placebo Controlled Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of BAY73-4506 in Combination With mFOLFOX6 or FOLFIRI as First or Second Line Therapy in Patients With Metastatic Colorectal.
- Colorectal Neoplasms;C20 - Malignant neoplasm of rectum
- Germany
- 2012-04-24
Not recruiting
- Vargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian Cancer
- Ovarian Cancer
- France
- 2012-04-19
Not recruiting
- First Line Treatment by FOLFIRINOX for Patients With a Rectum Cancer With Synchronous Non Resectable Metastasis
- Adenocarcinoma of Rectum
- France
- 2012-04-02
Not recruiting
- Integration of Follow-up by First and Second Line Practitioners by Telemonitoring in Heart Failure.
- Chronic Heart Failure
- Belgium
- 2012-03-29
Not recruiting
- An Observational Study of Avastin in First Line in Elderly Patients With Metastatic Colorectal Cancer (CASSIOPEE)
- Colorectal Cancer
- Finland, France
- 2012-03-14
Not Recruiting
- Dose-dense ABVD as first line therapy in early stage unfavorable Hodgkin’s Lymphoma: a phase II, prospective, multi-center study
- HODGKIN LIMPHOMA MedDRA version: 14.1 Level: SOC Classification code 10005329 Term: Blood and lymphatic system disorders System Organ Class: 10005329 - Blood and lymphatic system disorders ;Therapeutic area: Diseases [C] - Cancer [C04]
- Italy
- 2012-03-07
Not recruiting
- Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer
- Pancreatic Carcinoma.
- Sweden
- 2012-02-28
Not Recruiting
- Randomised, Multicenter Phase III Clinical Study of Lipoplatin plus Gemcitabine Versus Gemcitabine as First-Line Treatment in Inoperable, Locally Advanced or Metastatic Pancreatic Cancer
- Patients with Inoperable, Locally Advanced or Metastatic Pancreatic Cancer, not previously treated with chemotherapy for the current disease;Therapeutic area: Diseases [C] - Cancer [C04]
- China, France, Germany, Greece, Israel, Italy, Poland, Romania, Russian Federation, Spain, Taiwan, Turkey, United Kingdom, United States
- 2012-02-01
Not recruiting
- Efficacy of Fingolimod in de Novo Patients Versus Fingolimod in Patients Previously Treated With a First Line Disease Modifying Therapy
- Relapsing Remitting Multiple Sclerosis;Relapsing Remitting Multiple Sclerosis;Relapsing Remitting Multiple Sclerosis;Relapsing Remitting Multiple Sclerosis
- Australia, Spain
- 2011-12-19
Not recruiting
- A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
- Colorectal Cancer;Colorectal Cancer;Colorectal Cancer;Colorectal Cancer
- Australia, Austria, Belgium, Canada, Czech Republic, Finland, Hungary, Italy, Netherlands, Spain, United Kingdom, United States
- 2011-11-21
Not recruiting
- Efficacy and Safety of Simtuzumab With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
- Colorectal Cancer
- France, Germany, Italy, Poland, Russian Federation, Spain, United States
- 2011-11-09
Not Recruiting
- AN OPEN-LABEL, RANDOMISED PHASE 1B/2 STUDY OF PF-04691502 IN COMBINATION WITH LETROZOLE COMPARED WITH LETROZOLE ALONE IN PATIENTS WITH ESTROGEN RECEPTOR POSITIVE, HER-2 NEGATIVE EARLY BREAST CANCER
- ESTROGEN RECEPTOR POSITIVE, HER-2 NEGATIVE EARLY BREAST CANCER WITH KI-67 HIGHER THAN 10% AND ESTROGEN RECEPTOR POSITIVE, HER-2 NEGATIVE ADVANCED BREAST CANCER MedDRA version: 14.1 Level: LLT Classification code 10070575 Term: Estrogen receptor positive breast cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Germany, Spain, Sweden, United Kingdom
- 2011-10-10